sitagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetul zaharat, tip 2 - medicamente utilizate în diabet - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. , terapie triplă) ca adjuvant la dietă și exercițiu fizic, la pacienți controlați inadecvat cu doza maximă tolerată de metformin și o sulfoniluree. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
sitagliptin / metformin hydrochloride mylan
mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetul zaharat, tip 2 - medicamente utilizate în diabet - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , terapie triplă) ca adjuvant la dietă și exercițiu fizic, la pacienți controlați inadecvat cu doza maximă tolerată de metformin și o sulfoniluree. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
metformin actavis 850 mg comprimate filmate
actavis group ptc ehf. - metforminum - comprimate filmate - 850 mg
metformin actavis 500 mg comprimate filmate
actavis group ptc ehf. - metforminum - comprimate filmate - 500 mg
metformina arena 500 mg
arena group s.a. - romania - metforminum - compr. - 500mg - antidiabetice orale si parenterale, exclusiv insuline biguanide
metformina arena 850 mg
arena group s.a. - romania - metforminum - compr. - 850mg - antidiabetice orale si parenterale, exclusiv insuline biguanide
metformina arena 1000 mg
arena group s.a. - romania - metforminum - compr. - 1000mg - antidiabetice orale si parenterale, exclusiv insuline biguanide
metformin aurobindo 500 mg
milpharm limited - marea britanie - metforminum - compr. film. - 500mg - antidiabetice orale si parenterale, exclusiv insuline biguanide
metformin aurobindo 850 mg
milpharm limited - marea britanie - metforminum - compr. film. - 850mg - antidiabetice orale si parenterale, exclusiv insuline biguanide
metformin aurobindo 1000 mg
milpharm limited - marea britanie - metforminum - compr. film. - 1000mg - antidiabetice orale si parenterale, exclusiv insuline biguanide